Alaa H M Abdelrahman

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 14

Top Topics

Molecular Dynamics

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Dina E M Mohamed, Khlood A A Abdeljawaad, Mohamed Ahmed Naeem, Gamal A Gabr, Ahmed Mahmoud Shawky, Mahmoud E S Soliman, Peter A Sidhom, Paul W Paré, Mohamed-Elamir F Hegazy
Chetomin, a SARS-CoV-2 3C-like Protease (3CL pro ) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis. Viruses 15 (1) (2023)
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Dina E M Mohamed, Khlood A A Abdeljawaad, Mohamed Ahmed Naeem, Gamal A Gabr, Ahmed Mahmoud Shawky, Mahmoud E S Soliman, Peter A Sidhom, Paul W Paré, Mohamed-Elamir F Hegazy
Chetomin, a SARS-CoV-2 3C-like Protease (3CL pro ) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis. Viruses 15 (1) (2023)
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Dina E M Mohamed, Khlood A A Abdeljawaad, Mohamed Ahmed Naeem, Gamal A Gabr, Ahmed Mahmoud Shawky, Mahmoud E S Soliman, Peter A Sidhom, Paul W Paré, Mohamed-Elamir F Hegazy
Chetomin, a SARS-CoV-2 3C-like Protease (3CL pro ) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis. Viruses 15 (1) (2023)
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Dina E M Mohamed, Khlood A A Abdeljawaad, Mohamed Ahmed Naeem, Gamal A Gabr, Ahmed Mahmoud Shawky, Mahmoud E S Soliman, Peter A Sidhom, Paul W Paré, Mohamed-Elamir F Hegazy
Chetomin, a SARS-CoV-2 3C-like Protease (3CL pro ) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis. Viruses 15 (1) (2023)
Mahmoud A A Ibrahim, Khlood A A Abdeljawaad, Alaa H M Abdelrahman, Peter A Sidhom, Ahmed M Tawfeek, Gamal A H Mekhemer, Mohamed K Abd El-Rahman, Eslam Dabbish, Tamer Shoeib
In-Silico Mining of the Toxins Database (T3DB) towards Hunting Prospective Candidates as ABCB1 Inhibitors: Integrated Molecular Docking and Lipid Bilayer-Enhanced Molecular Dynamics Study. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Dina E M Mohamed, Khlood A A Abdeljawaad, Mohamed Ahmed Naeem, Gamal A Gabr, Ahmed Mahmoud Shawky, Mahmoud E S Soliman, Peter A Sidhom, Paul W Paré, Mohamed-Elamir F Hegazy
Chetomin, a SARS-CoV-2 3C-like Protease (3CL pro ) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis. Viruses 15 (1) (2023)
Mahmoud A A Ibrahim, Mahmoud M H Abdelhamid, Khlood A A Abdeljawaad, Alaa H M Abdelrahman, Gamal A H Mekhemer, Peter A Sidhom, Shaban R M Sayed, Paul W Paré, Mohamed-Elamir F Hegazy, Tamer Shoeib
Pyronaridine as a Bromodomain-Containing Protein 4- N -Terminal Bromodomain (BRD4-BD1) Inhibitor: In Silico Database Mining, Molecular Docking, and Molecular Dynamics Simulation. Molecules (Basel, Switzerland) 28 (15) (2023)
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Laila A Jaragh-Alhadad, Montaser A M Al-Hammady, Othman R Alzahrani, Muhammad Naeem Ahmed, Moustafa Sherief Moustafa, Mahmoud E S Soliman, Ahmed Mahmoud Shawky, Paul W Paré, Mohamed-Elamir F Hegazy, Peter A Sidhom
Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Nahlah Makki Almansour, Alaa H M Abdelrahman, Ekram Ismail Fagiree, Mahmoud A A Ibrahim
In silico drug repurposing and lipid bilayer molecular dynamics puzzled out potential breast cancer resistance protein (BCRP/ABCG2) inhibitors. Journal of biomolecular structure & dynamics (2022)
Mahmoud A A Ibrahim, Khlood A A Abdeljawaad, Alaa H M Abdelrahman, Laila A Jaragh-Alhadad, Hesham Farouk Oraby, Eslam B Elkaeed, Gamal A H Mekhemer, Gamal A Gabr, Ahmed Mahmoud Shawky, Peter A Sidhom, Mahmoud E S Soliman, Mahmoud F Moustafa, Paul W Paré, Mohamed-Elamir F Hegazy
Exploring Natural Product Activity and Species Source Candidates for Hunting ABCB1 Transporter Inhibitors: An In Silico Drug Discovery Study. Molecules (Basel, Switzerland) 27 (10) (2022)
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Khaled S Allemailem, Ahmad Abdulaziz A Almatroudi, Mahmoud F Moustafa, Mohamed-Elamir F Hegazy
In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors. The protein journal 40 (3) (2021)
Mahmoud A A Ibrahim, Khlood A A Abdeljawaad, Alaa H M Abdelrahman, Othman R Alzahrani, Fahad M Alshabrmi, Esraa Khalaf, Mahmoud F Moustafa, Faris A Alrumaihi, Khaled S Allemailem, Mahmoud E S Soliman, Paul W Paré, Mohamed-Elamir F Hegazy, Montaser A M Al-Hammady
Non-β-Lactam Allosteric Inhibitors Target Methicillin-Resistant Staphylococcus aureus: An In Silico Drug Discovery Study. Antibiotics (Basel, Switzerland) 10 (8) (2021)
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Tarik A Mohamed, Mohamed A M Atia, Montaser A M Al-Hammady, Khlood A A Abdeljawaad, Eman M Elkady, Mahmoud F Moustafa, Faris A Alrumaihi, Khaled S Allemailem, Hesham R El-Seedi, Paul W Paré, Thomas Efferth, Mohamed-Elamir F Hegazy
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors. Molecules (Basel, Switzerland) 26 (7) (2021)
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Montaser A M Al-Hammady, Tarik A Mohamed, Mahmoud F Moustafa, Abdulrahim Refdan Hakami, Shaden A M Khalifa, Fahad A Alhumaydhi, Faris A Alrumaihi, Syed Hani Abidi, Khaled S Allemailem, Thomas Efferth, Mahmoud E Soliman, Paul W Paré, Hesham Rushdy El-Seedi, Mohamed-Elamir F Hegazy
Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition. Marine drugs 19 (7) (2021)